Interleukin-12 (IL-12) is an important cytokine for maintainence of normal systemic defense and bioregulation. The Japanese herbal medicine Sho-saiko-to (TJ-9) has been administered to 1.5 million Japanese patients with chronic liver diseases. TJ-9 is known to significantly suppress cancer development in the liver and has macrobiotic effects. In the present study, we examined the in vitro production of IL-12 by circulating mononuclear cells from liver cirrhosis patients and the effects of TJ-9 on IL-12 production.
INTRODUCTION
Interleukin-12 (IL-12) is known as the natural killer cell stimulating factor (Kobayashi et al., 1989) , and its stimulatory effects are reported to be 100 to 1000 times more potent than that of (Robertson et al., 1992; Chehimi et al., 1993b) . The clinical application of IL-12 to cancer and immunodeficiency disease has been considered, because in vitro IL-12 improves the decreased cell-mediated immune responses and NK cell activity in patients with HIV infection (Chehimi et al., 1993a (Chehimi et al., , 1994 ; Clerici et al., 1993) , and when administered to mice transplanted tumors disappear (Brunda et al., 1994) . Recently, we reported that IL-12 production capacity of circulating monocyte/macrophages correlated with prognosis of chronic hepatitis C patients (Yamashiki et al., 1997a) .
Herbal medicines, which have been used in China for several thousand years, are increasingly being used among practioners of Western medicine in Japan. In particular, Sho-saiko-to (TJ-9;
Xiao-Chai-Hu-Tang in Chinese), which has been used for pyretic diseases in China, has been officially approved in Japan as a medicine for hospital use with standard quality and quantity of each component, and it has now been prescribed to approximately 1.5 million patients with chronic viral liver diseases. There have been many Japanese studies on its clinical usefulness (Oka et al., 1984; Fujiwara et al., 1987; Tajiri et al., 1990 ) TJ-9 is well known to gradually improve the subjective symptoms and abnormal liver function of patients with chronic viral liver diseases. Recently, TJ-9 was reported to induce apoptosis in vitro of hepatocellular carcinoma cell lines (Yano et al., 1994) , and a 5-year-olSservation of viral liver cirrhosis patients treated with or without TJ-9 demonstrated that TJ-9 significantly suppressed liver cancer development, and had macrobiotic effects (Oka et al., 1995) . These findings elicited considerable responses, from researchers. Some Japanese studies reported that TJ-9 enhances NK activities (Mizoguchi et al., 1986) , and we have also demonstrated that TJ-9 induces various cytokines (Yamashiki et al., 1994 (Yamashiki et al., , 1996 (Yamashiki et al., , 1997b . Nowadays, TJ-9 has come to be considered as a biological response modifier.
Considering the importance of IL-12 in cancer and immunodeficiency diseases, the present study investigated the effects of TJ-9 on IL-12 production in the adherent cell (monocyte/macrophage) fraction and in the non adhered cell (lymphocyte) fraction of peripheral blood mononuclear cells (MNC) that were obtained from liver cirrhosis patients and healthy subjects. In addition, it compared the IL-12 production indices for each of the seven herb components of TJ-9.
RESULTS
Interleukin 12 production in the Monocyte/Macrophage Fraction In the Me fraction, IL-12 production levels were decreased in the patient group compared to healthy subjects: that is, in cultures with medium only, IL-12 production was 256 +_ 54 pg/ml (mean + SE) in patients, and 650 + 139 pg/ml in a healthy subjects (p < 0.05, Table I ). After SEB induction, IL-12 production levels were 1146 _ _ 181 pg/ml in patients and 2773 + 491 pg/ml in a healthy subjects (p < 0.01). On the other hand, with TJ-9 in the cultures, the production levels in the both groups were increased to approximately three fold, that is, 765 + 130 pg/ml in patients and 2183 _ 223 pg/ml in a healthy subjects.
Interleukin 12 Production in the Lymphocyte

Fraction
In the lymphocyte fraction, the IL-12 production levels in patients tended to be lower than in a healthy subjects, and after SEB induction, these levels were 310 + 57 pg/ml in patients and 720 + 132 pg/ml in healthy subjects (p < 0.05). With TJ-9, the production increased by three times or more in the patients, and by six times or more in the healthy subjects.
Comparison of Seven Herb Components
In the comparison of the production index when a herb component, TJ-9, or SEB, was added to the Me or lymphocyte fraction of healthy subjects, high scores were obtained for the scutellaria root (index score: 5.9), glycyrrhiza root (3.7), and bupleurum root (2.6) in the Me fraction (Table II) , and in the lymphocyte fraction, high scores were obtained for scutellaria root (9.4) and glycyrrhiza root (4.4). The index scores for the remaining five herb components were lower than 1.7. (Yamashiki et al., 1997a) .
The usual daily dose of TJ-9 is 7.5 g, and this contains 4.5 g of dried extract obtained from bupleurum root, 7 g; pinellia tuber, 5 g; scutellaria root, 3 g; jujube fruit, 3 g; ginseng root, 3 g; glycyrrhiza root, 2 g; and ginger rhizome, 1 g. In the comparison of the production indexes, we used each herb component at the same concentration. We found that IL-12 was induced mainly by the scutellaria root and then by the glycyrrhiza root. These findings were similar to those found for the induction of TNF-c (Yamashiki et al, 1996) . The major chemical content of scutellaria root is bicalin and that of glycyrrhiza root is glycyrrhizin.
However, in an examination using these chemical compounds, no induction of IL-12 was observed (data not shown). Therefore, the IL-12 induction observed for the two herb components might be attributable to unknown chemical components.
TJ-9 strongly induces the production of various cytokines, in particular, IL-1 , IL-10, tumor necrosis factor alpha (TNF-(x), and granulocyte colony-stimulating factor (G-CSF), by peripheral mononuclear cells (Yamashiki et al., 1994 (Yamashiki et al., , 1996 (Yamashiki et al., , 1997b . These effects are similar to those of LPS. To confirm that the observed in vitro TJ-9 effects were not induced by the mixed LPS into the TJ-9 bulk powder (which contains 0.00067% of LPS), we also examined IL-12 production by using reagents that were treated with taxol (an LPS antagonist; Wako Pure Chemical Industries, Osaka). As a result, LPS-induced IL-12 production in the Me fraction decreased by approximately 1/2 to 1/6 with taxol treatment, but IL-12 production induced by TJ-9 was not affected by taxol treatment. Therefore, we consider that increased IL-12 production in cultures with TJ-9 is not the result of mixed LPS in the culture but is specific to TJ-9. In addition, because the highest serum concentration of TJ-9 after 1 week of administration is presumed to be 200 to 300 tg/ml (Yano et al., 1994) . the final concentration of TJ-9 used in this study (100 tg/ml) would be practical.
It is impossible to demonstrate the in vivo IL-12 induction by TJ-9 in patients with liver cirrhosis because the IL-12 level in the circulating blood is lower than minimum level measurable and also because the possibility of macrophages being activated and producing IL-12 without adhering to tissues is low. It would be worthwhile to investigate the changes in IL-12 producing cells of the organs such as the liver, spleen, lung, and lympho nodes from patients with liver cirrhosis, together with the expression of IL-12 messenger RNA in these organ tissues, and their changes after TJ-9 treatment.
Some of the advantages of herbal medicines are that their side effects are much milder than chemically produced drugs, and the herb moderately modifies the biological defense mechanism. However, at the same time, their moderate effects are a disadvantage: their efficacy in a short period of time is rather difficult to confirm, and many physicians, not only in Europe or the United States, but also in Japan, have doubted the efficacy of herbal medicines. In Japan, there have been 66 cases reported of interstitial pneumonia during TJ-9 treatment, mainly in hepatitis C patients. Although this incidence is quite low (far less than 0.01%) in the entire patients who received TJ-9 (approximately 1.5 million persons), 9 patients have died. This unfortunate event, however, also happens to indirectly suggest the effects of TJ-9 on the immunoregulation system.
Liver cancer is thought to occur within 10 years in 50% of viral liver cirrhosis patients. Induction of IL-12 may be useful to prevent cancer development, and IL-12 induction by TJ-9 could be an explanation for the macrobiotic effects of TJ-9 observed in the 5-year study of liver cirrhosis patients (Oka et al, 1995) In addition, because TJ-9 suppresses HIV proliferation in vitro, it may also be useful in the treatment of malignant diseases or immunodeficient diseases, including HIV infections (Buimovici-Klein et al., 1990) . Through the clarification of the true immunological effects of herbal medicines, physicians may be able to obtain a novel and highly useful biological modifier, and herbal medicines could be an efficacious remedy for immune-related diseases as well as infectious diseases.
MATERIALS AND METHODS
Patients and Controls
Peripheral blood was collected from 11 liver cirrhosis patients and 12 healthy volunteers (university students or employees). They understood the purpose of this study, and consent was given for the blood sampling and its use in this study. The 11 patients were hepatitis C virus (HCV)-positive. The ages and sexes of the patients and the controls were roughly similar.
Cell Preparation
As Jdescribed in our previous studies (Yamashiki et al., 1994 (Yamashiki et al., , 1996 (Yamashiki et al., , 1997a (Yamashiki et al., , 1997b , heparinized peripheral venous blood was collected, and the mononuclear cell (MNC) fraction was obtained using the lymphocyte separation solution (Muto Pure Chemicals, Tokyo). The MNC fraction was washed 3 times with Roswell Park Memorial Institute (RPMI) medium 1640 (Gibco Laboratories, Grand Island, NY) , and suspended at a density of 1 x 106cells/ml in the RPMI culture medium supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco Laboratories) and two antibiotics (Flow laboratories, Irvine, Scotland) , that is, penicillin 50 IU/ml (final concentration) and streptomycin 50 gg/ml. In all the following experiments except for washing, we used this MNC suspended RPMI medium (MNC suspension Statistical analyses on the differences of production levels between the healthy subjects and liver cirrhosis patients were carried out using non paired t-test (Student's t-test and Welch's t-test).
